This article was written by

Follow

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given that any particular security, portfolio, transaction or investment strategy is suitable for any specific person. The author is not advising you personally concerning the nature, potential, value or suitability of any particular security or other matter. You alone are solely responsible for determining whether any investment, security or strategy, or any product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation. Steven Cress is the Head of Quantitative Strategy at Seeking Alpha. Any views or opinions expressed herein may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

Columbia Threadneedle Investments is a leading global asset management group that provides a broad range of actively managed investment strategies and solutions for individual, institutional and corporate clients around the world. Columbia Threadneedle Investments is the global asset management group of Ameriprise Financial, Inc. (NYSE: AMP). For more information please visit columbiathreadneedleus.com.

PORTLAND, Ore. — Victor Wembanyama remains in the NBA’s concussion protocol and is listed as questionable for Sunday’s Game 4 against the Portland Trail Blazers, leaving the San Antonio Spurs to prepare for another critical playoff contest without their 7-foot-4 superstar just days after a frightening head-first fall.

The 22-year-old Defensive Player of the Year suffered the concussion in Game 2 on April 21 when he was fouled and crashed face-first to the court in San Antonio. He played only 12 minutes, recording five points before exiting and entering league protocol. The Spurs have since split the first three games of the Western Conference first-round series without him, winning Game 3 in Portland on Friday night 120-108 to take a 2-1 lead.

Spurs coach Mitch Johnson confirmed Saturday that Wembanyama continues progressing through the return-to-play steps but has not been cleared. “We’re still running through the process and continuing to work with the NBA,” Johnson said. The team has emphasized caution with the young phenom’s long-term health over rushing him back in a best-of-seven series.

The Scary Fall That Changed the Series

Wembanyama’s injury occurred with under nine minutes left in the second quarter of Game 2. After contact with Portland’s Jrue Holiday, the towering Frenchman fell awkwardly, his jaw slamming into the hardwood. He lay motionless briefly with eyes closed before walking to the locker room under his own power but was ruled out for the remainder of the contest.

Medical staff diagnosed a concussion. Per NBA guidelines, players cannot engage in full activity for at least 48 hours and must complete a graduated return-to-play protocol, including symptom-free benchmarks, exertion tests and clearance from both team physicians and league experts. The median absence for NBA concussions hovers around seven to nine days.

Wembanyama traveled with the team to Portland and has increased light activity, including cardio work. He was on the bench for Friday’s Game 3 victory, providing encouragement to teammates. Yet full participation Sunday at 3:30 p.m. ET on ESPN remains uncertain.

Spurs’ Resilience Without Their Franchise Cornerstone

San Antonio proved it can compete without Wembanyama in Game 3. Stephon Castle exploded for 33 points, while De’Aaron Fox and others stepped up in a balanced attack. The Spurs’ depth — built around young talent and veterans — has been tested early in these playoffs.

Still, the absence is felt on both ends. Wembanyama’s rim protection, rebounding and spacing are unmatched. In Game 1, he dropped 35 points in his playoff debut during a 111-98 victory. His presence forces defenses to adjust schemes that Portland has exploited in his absence.

Johnson has leaned on Luke Kornet in the starting lineup, with solid contributions from the bench. The coach praised the group’s adaptability: “We’ve got a lot of guys who are ready to play big minutes and make big plays.” But everyone understands the gap when the franchise face is sidelined.

Concussion Protocol: Safety First

The NBA’s concussion protocol, strengthened over years following high-profile cases, prioritizes player safety. Symptoms can include headaches, dizziness, sensitivity to light or cognitive fog — none of which can be rushed. Experts note that young athletes like Wembanyama, still developing physically, benefit from conservative management to avoid second-impact syndrome or prolonged recovery.

Analysts suggest a potential return for Game 5 in San Antonio on Tuesday is more realistic if he progresses well. The Spurs hold home-court advantage and lead the series, providing some margin, but a deep run without their MVP finalist would be challenging.

Wembanyama’s Rise and Stakes

Drafted No. 1 overall in 2023, Wembanyama has transformed the Spurs from lottery regulars into a 62-20 powerhouse this season. He earned unanimous Defensive Player of the Year honors and MVP finalist status, averaging elite numbers while anchoring one of the league’s best defenses. His unique blend of size, skill and basketball IQ has drawn comparisons to legends, but his health remains paramount at age 22.

The injury comes at a pivotal moment. Portland, led by Scoot Henderson’s scoring bursts, has shown fight, evening the series in Game 2 after Wembanyama exited. Blazers fans have embraced the underdog role, packing Moda Center for raucous home games.

Broader Implications for Spurs and Playoffs

San Antonio’s front office built this roster for sustained contention around Wembanyama. Missing time early in the postseason tests that vision but also highlights depth acquired through smart drafting and trades, including the addition of Fox. A series victory without him would boost confidence, yet his return could shift momentum dramatically.

League-wide, the case underscores ongoing discussions about load management, injury prevention and star availability in the playoffs. Teams balance competitive urgency with medical prudence, especially with a generational talent whose career trajectory could define the franchise for a decade.

What to Watch Sunday

If Wembanyama is ruled out, expect heavy minutes for the supporting cast. Portland will likely continue aggressive schemes targeting the paint and perimeter. If he plays, even in a limited role, his mere presence could alter defensive rotations and energize the Spurs.

Fans and analysts await the final injury report closer to tip-off. Wembanyama has expressed eagerness to return but deferred to medical staff. His teammates remain focused on the task at hand, echoing Johnson’s message of resilience.

The Spurs-Blazers series has delivered drama, from Wembanyama’s record-setting playoff debut to his scary fall and the team’s road resilience. As Game 4 unfolds, all eyes remain on the sideline — hoping for the towering figure in No. 1 to check in, while understanding the bigger picture of his health.

Whatever the outcome Sunday, the narrative centers on Wembanyama’s recovery. For a Spurs team built around him, every step in protocol brings them closer to full strength as they chase a deeper playoff run.

This article was written by

Follow

Analyst’s Disclosure: I/we have a beneficial long position in the shares of HBAN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

HOUSTON — Los Angeles Lakers star Luka Doncic has been officially ruled out for Sunday’s Game 4 against the Houston Rockets, extending his absence due to a Grade 2 left hamstring strain as the Western Conference first-round series reaches a critical juncture with the Lakers holding a commanding 3-0 lead.

The Slovenian superstar, acquired by the Lakers in a blockbuster move that reshaped the franchise’s future, has not played since early April when he suffered the injury in a loss to the Oklahoma City Thunder. Despite making progress in his rehabilitation, including light on-court work and specialized treatment overseas, Doncic remains sidelined indefinitely with no return expected in the first round.

Lakers coach JJ Redick and team officials have emphasized caution. A Grade 2 hamstring strain involves a partial tear of muscle fibers, typically requiring four to six weeks for recovery. Doncic’s timeline aligns with that window, pushing any potential return toward early May at the earliest — possibly Game 6 if the series extends.

Injury Details and Recovery Progress

Doncic first felt the hamstring issue late in the first half against the Thunder on April 2. He attempted to play through it but exited after grabbing at his leg during a drive. An MRI confirmed the Grade 2 strain, sidelining him for the final stretch of the regular season.

He traveled to Europe for advanced treatment, reportedly including regenerative therapies, and has since ramped up activity at the Lakers’ practice facility. Recent sessions included jump shots and light movement, signaling forward momentum without setbacks. Still, the organization has been deliberate.

ESPN’s injury report listed an estimated return around May 1, coinciding with a potential Game 6, but Shams Charania reported the Lakers do not anticipate his availability this series. Austin Reaves, dealing with his own oblique strain, is further along in rehab and listed as questionable.

Lakers’ Resilience Without Their Stars

Despite missing their top two scorers in Doncic and Reaves for much of the series, the Lakers have dominated. LeBron James has delivered vintage performances, averaging over 25 points with elite playmaking. Role players like Luke Kennard, Rui Hachimura and Marcus Smart have stepped up dramatically.

In Game 3 on Friday, Los Angeles survived an overtime thriller in Houston, winning 112-108 to take the 3-0 advantage. James posted 29 points, 13 rebounds and six assists, while the supporting cast neutralized Houston’s young core.

The victory showcased the depth built around James and the defensive versatility Redick has instilled. Yet the absences have forced heavy minutes on veterans and stretched rotations, making a sweep on Sunday night a statement of organizational strength.

Rockets’ Struggle and Key Matchups

Houston, the fifth seed, entered the series with momentum but has been unable to capitalize on Los Angeles’ injuries. Alperen Sengun has been a force inside, but the Rockets have struggled to contain James and the perimeter shooting from Kennard.

Kevin Durant remains questionable with an ankle issue, adding to Houston’s challenges. Fred VanVleet and Steven Adams are out for the series, thinning the Rockets’ rotation further. A Game 4 win for Houston would force the series back to Los Angeles, but the mounting deficits and injuries have tested their resilience.

Broader Impact on Lakers’ Season

Doncic’s acquisition before the season signaled championship aspirations. The 27-year-old averaged elite numbers, elevating the Lakers’ offense with his playmaking, scoring and vision. His absence has tested the roster’s chemistry but also highlighted LeBron’s enduring greatness at 41 and the contributions of complementary pieces.

A sweep would advance Los Angeles to the Western Conference semifinals, where matchups against higher seeds await. Doncic’s potential return later in the postseason could transform their outlook, providing a dynamic backcourt threat alongside a healthy Reaves.

Management’s conservative approach reflects lessons from past hamstring injuries that have derailed star players. Rushing back risks re-injury and longer absences, particularly in a grueling playoff run.

What to Expect in Game 4

Tip-off is set for 9:30 p.m. ET on NBC and Peacock at Toyota Center. The Lakers will aim to close out the series with similar execution: strong defense, timely three-point shooting and James orchestrating the attack. Houston must find answers for James while hoping for a heroic effort from Sengun and supporting cast.

Fans in Los Angeles and beyond will watch anxiously for any signs of Doncic’s progress, though Sunday’s focus remains on the court. A victory without him would further validate the team’s depth and set up a compelling second-round story.

The 2026 playoffs have already delivered drama, with the Lakers proving adaptable amid adversity. As Game 4 unfolds, the narrative centers on whether the short-handed visitors can punch their ticket forward — and how soon their superstar guard can rejoin the quest.

This article was written by

Follow

Analyst’s Disclosure: I/we have a beneficial long position in the shares of AMZN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.